The US Bankruptcy Court gave an order approving the sale of the certain assets of Akorn Holding Company, Inc. on October 16, 2023. The debtor has been authorized to sell its certain assets to Domes Pharma, Inc. for a purchase price of $0.35 million in cash pursuant to the asset purchase agreement dated September 22, 2023. The debtor?s assets include Estate Rights and Title.

The transaction is expected to close on October 16, 2023.